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Abstract
The 2013 International Conference on Intelligent Biology and Medicine (ICIBM 2013) was held on August 11-13,
2013 in Nashville, Tennessee, USA. The conference included six scientific sessions, two tutorial sessions, one
workshop, two poster sessions, and four keynote presentations that covered cutting-edge research topics in
bioinformatics, systems biology, computational medicine, and intelligent computing. Here, we present a summary
of the conference and an editorial report of the supplements to BMC Genomics and BMC Systems Biology that
include 19 research papers selected from ICIBM 2013.
Introduction
Built upon the success of last year’s conference [1-4],
the 2013 International Conference on Intelligent Biology
and Medicine (ICIBM 2013) was held on August 11-13,
2013 in Nashville, Tennessee, USA. The primary goal of
the conference remains to foster interdisciplinary and
multidisciplinary research and to provide education and
training opportunities to students and junior investigators
who are interested in bioinformatics, systems biology, or
intelligent computing. The conference brought together
more than 110 participants with diverse backgrounds
spanning biology, medicine, computer science, bioengi-
neering, statistics, and mathematics, among others.
We received 65 manuscript and 37 abstract submissions.
Compared to last year, we continue to have steady submis-
sions on topic areas including biological network analysis,
network medicine, and next-generation sequencing (NGS)
data analysis. An emerging research area at ICIBM is
proteomics-based research and applications. Thanks to
grant support from the National Science Foundation,
we were able to provide 21 travel awards to trainees from
19 universities across both the USA and international
institutions. The travel awards were selected by the Award
Committee from a substantial number of outstanding
manuscripts and abstracts that spanned the wide variety of
research subjects. In the following section, we present a
summary of the scientific program of the conference and
an editorial report of the supplements to BMC Genomics
and BMC Systems Biology.
ICIBM 2013 scientific program
The scientific program included four keynote speakers
who are world renowned leaders in biomedical infor-
matics, pharmacogenomics, bioinformatics, and systems
biology, six scientific sessions, two poster sessions, two
tutorials, and one workshop. Here, we briefly review the
keynote speakers’ lectures followed by the workshop,
tutorials, and regular scientific sessions.
Four keynote speakers presented their pioneering
research and shared their perspectives of relevant research
fields. These speakers were Dr. Lucila Ohno-Machado
from the University of California, San Diego, Dr. Dan
M. Roden from Vanderbilt University, Dr. A. Keith
Dunker from Indiana University, and Dr. Yixue Li from
the Chinese Academy of Sciences.
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“Sharing clinical and genomic data for research: Is it
simply a matter of trust?“ Dr. Ohno-Machado presented
different models for sharing clinical and genomic data
for research, which are designed to accommodate highly
diverse policies. She also discussed how her group is
currently implementing these models in several projects,
such as the University of California Research eXchange
initiative. Dr. Ohno-Machado is the Associate Dean for
Informatics and Technology at the School of Medicine,
University of California, San Diego, the founding Chief
of the Division of Biomedical Informatics, and a Professor
of Medicine. She is an elected fellow of the American
Institute for Medical and Biological Engineering, the
American College of Medical Informatics, and the American
Society for Clinical Investigation. She is the Editor-
In-Chief of the Journal of the American Medical Infor-
matics Association. Her research focuses on predictive
modeling, particularly including the evaluation of indi-
vidualized probabilistic estimates for risk assessment
and prognosis.
“Genetic variation modulating drug response: discovery
and implementation“ Dr. Roden introduced BioVU, a
resource that links DNA extracted from clinically-
obtained blood samples to their de-identified electronic
medical record (EMR). BioVU not only enables the dis-
covery of new genomic variants associated with specific
clinical phenotypes, but also new phenotypes associated
with specific genotypes (i.e. genetic pleiotropy) in an
approach Dr. Roden and his team termed “phenome-wide
association study” (PheWAS). Dr. Roden also presented
the Vanderbilt PREDICT (Pharmacogenomic Resource
for Enhanced Decisions in Care and Treatment) program
that empowers patients and doctors with the genetic infor-
mation needed to predict and help prevent adverse side
effects of drugs. Dr. Roden served as the Director of
the Vanderbilt Arrhythmia Service, the director of the
Division of Clinical Pharmacology (1992-2004), and in
2006 was named the Assistant Vice-Chancellor for Perso-
nalized Medicine. Dr. Roden has been elected to member-
ship in the American Society for Clinical Investigation and
the Association of American Physicians, and he is a fellow
of the American Association for the Advancement of
Science.
“An intrinsically disordered protein Swiss-Knife-like
toolkit for signaling diversification“ Dr. A. Keith Dunker
provided a comprehensive review of intrinsically disor-
dered proteins (IDPs) and their critical role as a multifa-
ceted, Swiss-Knife-like toolkit that enables swift (on an
evolutionary time scale) diversification of cell signaling
to facilitate the development of metazoans and their
rapid evolution. Dr. Dunker is a Professor of Biochemistry
and Molecular Biology at Indiana University, where he
launched the Center for Computational Biology and
Bioinformatics and served as its Director. He is best
known for his research in understanding IDPs using
bioinformatics approaches and laboratory experiments. He
and his collaborators were the first to consider these pro-
teins as a distinct class with important biological functions.
“Genome sequences of wild and domestic bactrian
camels“ Dr. Yixue Li presented draft genome sequences
from both a wild and a domestic Bactrian camel. The
study by Dr. Li and his team reveals the evolutionary
history of camels and provides insights on the genetic
basis of camels’ remarkable salt tolerance and unusual
immune system. Dr. Li is the Director of the Shanghai
Center for Bioinformation Technology, Vice Director
and Professor of the Key Laboratory of Systems Biology
at Shanghai Institutes for Biological Sciences, Chinese
Academy of Sciences. Dr. Li’s research interests include
bioinformatics, systems biology, and computational
biology.
ICIBM 2013 included one workshop and two tutorials
for educational purposes, all of which were much appre-
ciated by the conference participants.
“Workshop on Next-Generation Sequencing“ This
workshop was organized by Dr. Kun Huang from The
Ohio State University and Dr. Dongxiao Zhu from
Wayne State University. The workshop brought together
active researchers in the NGS field and provided an
opportunity for them to introduce cutting edge technol-
ogies and novel computational methodologies, discuss
challenges and opportunities, and interact with the
attendees. This workshop had three sessions and nine
talks. A majority of the talks introduced new methods
for NGS data analysis, including genotype calling, identi-
fying spontaneous mutations in bacteria, metagenomic
mining, peak-calling in ChIP-Seq experiments, network-
based detection of cancer driver genes, and analysis of
allele specific expression. Others presented interesting
applications of NGS technologies to studies in autism
spectrum disorder, cancer, and pharmacogenomics.
“Tutorial I: Introduction to Proteome Informatics“ This
tutorial was organized by Dr. David L. Tabb from Vander-
bilt University, and it had four instructors. The workshop
introduced major elements of the protein identification
and quantitation pipelines and describes a strategy for
proteogenomic experiments with both RNA-Seq and
proteomic data. The workshop provided a useful overview
of proteome informatics for computer scientists, bio-
informaticians, and statisticians who have not previously
worked with proteomics data sets.
“Tutorial II: Pathway and Network Analysis Tutorial“
This tutorial was provided by Dr. Alexander Pico from the
Gladstone Institutes and Dr. Jing Wang from Vanderbilt
University. Dr. Pico provided a general introduction to
WikiPathways, a collaborative platform for building,
curating, and distributing biological pathway knowledge
for the research community. He also provided a brief
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introduction to the powerful network visualization tool
Cytoscape. Dr. Wang introduced NetGestalt, a novel
web-based data integration framework that allows simul-
taneous presentation of large-scale experimental and
annotation data from various sources in the context of
biological networks to facilitate data visualization, analysis,
and interpretation.
ICIBM 2013 had six regular scientific sessions for
researchers to showcase their original works in the areas
of bioinformatics, systems biology, medical informatics,
and intelligent computing. The presenters were chosen
through a rigorous review process, and their work stood
out among the submissions as novel and significant.
These sessions were:
Session I: Next Generation Sequencing (NGS): Analysis
and Tools
Session II: Network Analysis
Session III: Genomics
Session IV: Systems Biology
Session V: Computational Medicine
Session VI: Intelligent Computing
The details of each session, including session chairs,
speakers, and the title and abstract of each talk, are
available online [5] and in the conference program book.
Here, we provide an editorial report of the supplements
to BMC Genomics and BMC Systems Biology that include
19 research papers selected from 65 manuscripts sub-
mitted to ICIBM 2013. Each manuscript was reviewed by
at least two reviewers (most by three reviewers) and went
through two rounds of reviews. Among the 19 selected
papers, 8 are devoted to network analysis methods and
their applications to disease studies. Four papers describe
new development or careful evaluation of methods for
NGS data analysis. Two papers employ proteomic or pro-
teogenomic approaches in human cancer studies. The
other papers cover a diverse range of topics.
Network analysis methods and applications
A large proportion of papers focused on network analysis
methods and their application to human disease studies.
Udyavar et al. [6] applied the weighted gene co-expression
network analysis in a lung cancer study and uncovered a
signature of signaling hubs closely associated with the
small cell lung cancer (SCLC) phenotype. Among the
identified hubs, tyrosine kinase SYK emerged as an unsus-
pected SCLC oncogenic driver and potential therapeutic
target. Yu et al. [7] integrated co-expression and the
protein interactome to identify network modules of
human diseases. The method outperformed the traditional
differential expression approach. Budd et al. [8] used a
network-based approach that determines the sum node
degree for all experimentally verified microRNA targets in
order to identify potential regulators of prostate cancer
initiation, progression, and metastasis. Shi et al. [9] devel-
oped a two-step approach for gene regulatory network
identification, featuring an integrated method to identify
modularized regulatory structures and subsequently refine
their target genes. Ma et al. [10] developed a tool for
modeling and visualizing the relationship between differ-
ent groups of compounds that share similar differential
gene expression signatures, termed “Mode of Actions,”
regarding their therapeutic effect. They then applied the
tool to a breast cancer study. Wu et al. [11] built a
weighted disease and drug heterogeneous network based
on known disease-gene and drug-target relationships and
then clustered the network to identify modules and infer
putative drug repositioning candidates. Liu et al. [12]
proposed the use of graph-based Laplacian regularized
logistic regression to integrate biological networks into
disease classification and pathway association problems.
The algorithm outperformed elastic net and lasso in the
simulation studies. The utility of the algorithm was also
validated through its ability in reliably differentiating
breast cancer subtypes using a breast cancer dataset from
The Cancer Genome Atlas (TCGA) consortium. Finally,
Jiang et al. [13] proposed a comprehensive framework
at the network level to integrate single nucleotide poly-
morphism (SNP) annotation, target gene assignment,
Gene Ontology classification, pathway enrichment analy-
sis, and regulatory network reconstruction to illustrate the
molecular functions of prostate cancer-associated SNPs.
NGS data analysis methods and applications
Several papers presented new methods or thorough eva-
luations of existing methods for the analysis of data
derived from metagenomic sequencing, ChIP-Seq, or
RNA-Seq. Srinivasan et al. [14] developed an alignment-
free n-gram-based method named MetaID that can
accurately identify microorganisms at the strain level and
estimate the abundance of each organism in a sample
given a metagenomic sequencing dataset. Liu et al. [15]
developed a novel quantitative method for comparing two
biological ChIP-Seq samples, called QChIPat. Their
method has several advantages. First, it considers a control
(or input) experiment; second, it incorporates a nonpara-
metric empirical Bayes correction normalization; more-
over, it provides the binding pattern information among
different enriched regions. Guo et al. [16] designed a
comprehensive experiment to evaluate six read count-
based RNA-Seq analysis methods (DESeq, DEGseq, edgeR,
NBPSeq, TSPM and baySeq) using both real and simu-
lated data. They found the six methods produce similar
fold changes and reasonable overlapping of differentially
expressed genes. However, all six methods suffered from
over-sensitivity. Compared to other methods, edgeR
achieved a better balance between speed and accuracy.
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Liu et al. [17] analyzed RNA-Seq data from kidney renal
clear cell carcinoma at both gene- and isoform-levels in an
attempt to uncover cancer-stage-dependent expression
signatures. They found that isoform expression profiling
provides unique and important information that cannot
be detected by gene expression profiles. Furthermore,
they showed combining gene and isoform expression
signatures helps identify advanced stage cancers, predict
clinical outcome, and present a comprehensive view of
cancer development and progression.
Proteomics in cancer research
Molecular cancer research has been dominated by geno-
mic technologies during the last decade. With recent
advancements in proteomics technologies, proteomics and
integrative proteogenomics now play an increasingly
important role in this field. Sun et al. [18] created the
database CanProFu that comprehensively annotates fusion
peptides formed by exon-exon linkage between these
pairing genes. They applied the database to mass spec-
trometry datasets of 40 human non-small cell lung
cancer (NSCLC) samples and 39 normal lung samples
and identified 11 NSCLC-specific gene fusion events.
Zhang et al. [19] presented a peptidomics approach to
search for novel alternative splicing isoforms in clinical
proteomics. Their results showed that the approach
has significant potential in enabling the discovery of
new types of high-quality alternative splicing isoform
biomarkers. Proteomics datasets have also been used
to confirm a SCLC gene expression signature identified
from microarray data [6].
Other papers in these supplements cover a diverse
range of topics. Dai et al. [20] comprehensively analyzed
the sequence origin of Pldi-Ak158810 loci, which origi-
nated from the inter-genic regions in mice after the diver-
gence of mice and rats. They found that various factors,
including rearrangement and transposable elements, con-
tributed to the formation of the sequence. To address the
multiple-test correction problem in expression quanti-
tative trail loci (eQTL) studies, Chakraborty et al. [21]
developed an approach that takes advantage of an empiri-
cal Bayes method and local false discovery rate (lfdr)
calculation. Their method better controls the false positive
rate compared to traditional methods. Tyaga et al. [22]
developed a 3D QSAR model that allows researchers to
correlate the structural features of thiosemicarbazone
group with their anticancer cathepsin L inhibitory activity
through the development of a robust 3D QSAR model.
Wang et al. [23] presented a comprehensive model with
128 features that allows accurate prediction of allergenic
proteins. They showed the value of the Maximum
Relevance Minimum Redundancy (mRMR) method
and Incremental Feature Selection (IFS) procedure in
feature selection. Lastly, Wang et al. [24] developed a
novel approach to automatically generate meaningful
annotations for gene sets that are directly tied to
relevant articles in literature.
Conference organization
2013 International Conference on Intelligent Biology and
Medicine (ICIBM 2013)
(August 11-13, 2013, Nashville, Tennessee, USA)
Our sincerest thanks to the members of our Steering,
Program, Publication, Workshop/Tutorial, Award, Publi-
city, Trainee, and Local Organization committees, as
well as our numerous reviewers and volunteers, for the
countless hours and energy spent to make ICIBM 2013
a success! We could not have accomplished so much
without the dedication of each and every person that
contributed to this conference.
Sponsors National Science Foundation, Vanderbilt
University (VU), Vanderbilt Center for Quantitative
Sciences, Bioinformatics Resource Center at Vanderbilt-
Ingram Cancer Center, International Society of Intelligent
Biological Medicine, University of Texas at San Antonio,
Shanghai Center for Bioinformation Technology, China,
Shanghai Institute for BioMedicine, China, and Shanghai
Jiao Tong University, China.
Partners Vanderbilt University (Center for Quantita-
tive Sciences, Bioinformatics Resource Center), Meharry
Medical College, and Tennessee State University.
General Chairs Zhongming Zhao (Vanderbilt Univer-
sity) and Yu Shyr (Vanderbilt University).
Steering Committee Chair: Zhongming Zhao
(Vanderbilt University). Members: Kevin Johnson
(Vanderbilt University), Tony Hu (Drexel University),
Jason Moore (Dartmouth College), Limsoon Wong
(National University of Singapore), Dong Xu (University of
Missouri - Columbia), Ying Xu (University of Georgia).
Program Committee Chair: Bing Zhang (Vanderbilt
University), Co-Chair: Jason E. McDermott (Pacific
Northwest National Laboratory), Members: Kristen
Anton (Dartmouth College), William S. Bush (Vanderbilt
University), Jake Chen (Purdue University), Xue-Wen
Chen (Wayne State University), Juan Cui (University of
Georgia), Qinghua Cui (Peking University), Youping
Deng (Rush University Medical Center), Joshua Denny
(Vanderbilt University), Jason Ernst (University of
California, Los Angeles), Jennifer M. Fettweis (Virginia
Commonwealth University), Marcelo Fiszman (National
Library of Medicine, National Institutes of Health),
Jan Freudenberg (Feinstein Medical Research Institute),
Ge Gao (Peking University), Mark Gerstein (Yale Univer-
sity), Chittibabu (Babu) Guda (University of Nebraska
Medical Center), Yan Guo (Vanderbilt University), Steve
Horvath (University of California, Los Angeles), Weichun
Huang, (National Institute of Environmental Health
Sciences), Yang Huang (Kaiser Permanente), Yufei
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Huang (University of Texas, San Antonio), Jenn-Kang
Hwang (National Chiao Tung University, Taiwan), Peilin
Jia (Vanderbilt University), Yufang Jin (University of
Texas, San Antonio), Victor Jin (University of Texas, San
Antonio), Sun Kim (Seoul National University, Korea),
Judith Klein-Seetharaman (University of Warwick, UK),
Dmitry Korkin (University of Missouri - Columbia), K.B.
Kulasekera (University of Louisville), Leping Li (National
Institute of Environmental Health Sciences), Liao Li
(University of Delaware), Honghuang Lin (Boston
University), Chunyu Liu (University of Chicago),
Hongfang Liu (Georgetown University), Qi Liu (Vanderbilt
University), Tianming Liu (University of Georgia), Yulong
Liu (Indiana University), Zhandong Liu (Baylor College
of Medicine), Zhiyong Lu (NCBI, National Library of
Medicine), Xinghua Lu (University of Pittsburgh), Patricio
A. Manque (Universidad Mayor, Chile), Ranadip Pal
(Texas Tech University), Yonghong Peng (University of
Bradford), Horacio Perez-Sanchez (Catholic University of
Murcia, Spain), Jiang Qian (Johns Hopkins University),
Thomas Rindflesch (National Institutes of Health),
Marylyn Ritchie (Penn State University), Bairong Shen
(Soochow University, China), Alexander Statnikov (New
York University Langone Medical Center), Jingchun
Sun (Vanderbilt University), Wing-Kin Sung (National
University of Singapore, Singapore), P.S. Thiagarajan
(National University of Singapore, Singapore), Manabu
Torii (Georgetown University Medical Center), Jun Wan
(Johns Hopkins University), Jing Wang (Vanderbilt
University), Yufeng Wang (University of Texas at
San Antonio), Qingguo Wang (Vanderbilt University),
Xiaoyan Wang (University of Connecticut), Yonghui Wu
(Vanderbilt University), Junfeng Xia (Anhui University,
China), Lu Xie (Shanghai Center for Bioinformation Tech-
nology, China), Hua Xu (The University of Texas Health
Science Center at Houston), Jianhua Xuan (Virginia
Tech), Sungroh Yoon (Seoul National University, Korea),
Yanqing Zhang (Georgia State University), Min Zhao
(Vanderbilt University), Huiru (Jane) Zheng (University of
Ulster), W. Jim Zheng (The University of Texas Health
Science Center at Houston), and Dongxiao Zhu (Wayne
State University).
Publication Committee Chair: Yufei Huang (Univer-
sity of Texas, San Antonio), Co-Chair: Yunlong Liu
(Indiana University).
Workshop/Tutorial Committee Chair: David Tabb
(Vanderbilt University).
Award Committee Chair: Hua Xu (The University of
Texas Health Science Center at Houston), Co-Chair:
Sachin Shetty (Tennessee State University), Member:
Siddharth Pratap (Meharry Medical College), Yonghui
Wu (The University of Texas Health Science Center at
Houston).
Publicity Committee Chair: Lang Li (Indiana Univer-
sity), Co-Chair: Lu Xie (Shanghai Center for Bioinforma-
tion Technology, China).
Trainee Committee Chair: Qingguo Wang (Vanderbilt
University), Co-Chair: Mario Flores (University of Texas
at San Antonio).
Local Organization Committee Chair: Rebecca H.
Posey (Vanderbilt University). Members: Jillanne K. Shell
(Vanderbilt University), Qi Liu (Vanderbilt University),
and Qingguo Wang (Vanderbilt University).
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